| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.48 | 0.08 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.09 |